The obesity paradox in heart failure: is it still valid in light of new therapies?

H Fröhlich, N Frey, L Frankenstein, T Täger - Cardiology, 2022 - karger.com
Background: Obesity increases the risk of cardiovascular disease and heart failure (HF).
However, in patients with established HF, many studies observed greater survival with …

Effect of beta‐adrenergic blockade with carvedilol on cachexia in severe chronic heart failure: results from the COPERNICUS trial

AL Clark, AJS Coats, H Krum, HA Katus… - Journal of cachexia …, 2017 - Wiley Online Library
Background Cardiac cachexia frequently accompanies the progression of heart failure
despite the use of effective therapies for left ventricular dysfunction. Activation of the …

Clinical evidence and potential mechanisms of traditional Chinese medicine for refractory heart failure: a literature review and perspectives

L Guo, Z Yang, W Feng, Y Liu, Z Li… - Frontiers in …, 2024 - frontiersin.org
Refractory heart failure (RHF), or end-stage heart failure, has a poor prognosis and high
case fatality rate, making it one of the therapeutic difficulties in the cardiovascular field …

Insulin-dependent metabolic and inotropic responses in the heart are modulated by hydrogen peroxide from NADPH-oxidase isoforms NOX2 and NOX4

B Steinhorn, JL Sartoretto, A Sorrentino… - Free Radical Biology …, 2017 - Elsevier
Abstract Rationale Hydrogen peroxide (H 2 O 2) is a stable reactive oxygen species (ROS)
that has long been implicated in insulin signal transduction in adipocytes. However, H 2 O …

Effect of beta-adrenergic blockade on weight changes in patients with chronic heart failure

S Sze, P Pellicori, S Kamzi, A Anton, AL Clark - International Journal of …, 2018 - Elsevier
Background Weight loss is common in patients with chronic heart failure (CHF) and is
associated with adverse outcome. Activation of the sympathetic nervous system has been …

Devices and interventions for the prevention of adverse outcomes of tachycardia on heart failure

J Devgun, YB Jobanputra, M Arustamyan, R Chait… - Heart failure …, 2018 - Springer
Heart failure (HF) is the leading cause of hospitalization in the USA. Despite advances in
pharmacologic management, the incidence of HF is on the rise and survivability is …

[PDF][PDF] Vagus nerve stimulation: Invasive or noninvasive?

Y Anfinogenova - The Anatolian Journal of Cardiology, 2016 - jag.journalagent.com
10. Frangos E, Ellrich J, Komisaruk BR. Non-invasive access to the vagus nerve central
projections via electrical stimulation of the external ear: fMRI Evidence in Humans. Brain …

Win 55,212-2, atenolol and subdiaphragmatic vagotomy prevent acceleration of gastric emptying induced by cachexia via Yoshida-AH-130 cells in rats

ML de Sousa Cavalcante, MS Silva… - European Journal of …, 2020 - Elsevier
The aim of this study was to investigate the effect of cachexia induced by AH-130 cells on
gastrointestinal motility in rats. We evaluated food intake, body weight variation, cachexia …

An effective treatment for heart failure caused by valvular heart diseases: Thoracic sympathetic block

D Li, W Liu, D Ma, F Yun, S Li, F Liu - Journal of Investigative …, 2018 - Taylor & Francis
Background: The pilot study is designed to investigate the effect of continuous thoracic
sympathetic block (TSB) on cardiac function, reconstruction, and hemodynamic parameters …

[PDF][PDF] INSUFICIENCIA CARDIACA CON FRACCION DE EYECCION REDUCIDA

DRJA PAREDES - Revista Peruana de Cardiología, 2019 - sopecard.org
a la ICFEP son personas mayores, frecuentemente mujeres con historia de hipertension
arterial (HTA) y fibrilacion auricular (FA), con menor historia de IMA (1). El termino de IC …